send $acb back to $100
Updated
2024 has been very busy for 
ACB
- Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia
- Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free
- Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis
- Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation
when looking at the chart we can see obvious price discovery to the downside, and the last year of lows have come with heavy market selling. however on the plus side the buy pressure has been positive in the background suggesting someone is happy to scoop up the stock down here.
its only a matter of time beforeACB picks up again given the company are now debt free :-)
ACB- Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia
- Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free
- Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis
- Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation
when looking at the chart we can see obvious price discovery to the downside, and the last year of lows have come with heavy market selling. however on the plus side the buy pressure has been positive in the background suggesting someone is happy to scoop up the stock down here.
its only a matter of time before
ACB picks up again given the company are now debt free :-)Note
"Kamala Harris Calls For Marijuana To Be Rescheduled 'As Quickly As Possible'"Note
look at that 3M truemo curve, thats about to go on a multi year tare again, last 2x 3M candles have had bullish buying despite the drop in price (hidden bull div). Just send this to ATH already, 30000% lfg!Note
Germany through the door, UK considering it - High times ahead guys!
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.